Skip to content
Screener

Innoviva, Inc. INVA Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$114.6MBeat by $12.0M
EPS$1.94Beat by $1.60
Revenue estimate$102.6M
EPS estimate$0.34

Next report

Nov 4, 2026 (in a month)
Revenue estimate$115.3M
EPS estimate$0.49

Financials

Q4 2025

Income statement

See full
Revenue$114.6M+24.8%
Gross profit$75.7M-3.2%
Operating income$39.0M-9.6%
Net income$164.2M+707%
EPS (diluted)$1.95+529%

Balance sheet

See full
Cash & equivalents$550.9M+80.7%
Total debt$269.0M-40.4%
Total equity$1.2B+69.7%
Total assets$1.6B+25.7%

Cash flow

See full
Operating cash flow$54.5M-8.0%
CapEx$10.0K—
Free cash flow$54.5M-8.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.49B+37.6%
Enterprise value$1.21B-1.6%
P/E5.5×-40.9×
P/S3.6×+0.6×

Profitability

See full
Gross margin74.8%-7.8pp
Operating margin39.8%-6.7pp
Net margin65.9%+59.4pp
FCF margin47.6%-4.9pp

Returns & leverage

See full
Return on equity29.1%—
Debt / equity0.2×-0.4×
Current ratio14.6×+12.3×

Segments

By product

See full
Giapreza$19.6M+21.6%
Cost Reimbursement-—

FAQ

When did Innoviva, Inc. report Q4 2025 earnings?
Innoviva, Inc. (INVA) reported Q4 2025 earnings on February 25, 2026 after market close.
What were Innoviva, Inc.'s Q4 2025 revenue and EPS?
Innoviva, Inc. reported revenue of $114.6M and eps of $1.94 for Q4 2025.
Did Innoviva, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $102.6M by $12.0M. EPS beat the consensus estimate of $0.34 by $1.60.
How did Innoviva, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 24.8% from $91.8M a year earlier and eps grew 240.4% from $0.57.
Where can I find Innoviva, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-071974) and the 10-K periodic report (0001193125-26-071776) directly on SEC EDGAR. The filing index links above go to sec.gov.